BCG’s Ashkan Afkhami discusses GenAI’s impact on trial efficiency, the challenge of scaling innovation, and why partnerships are key to driving health care transformation this year.
Education
- Harvard Kennedy School, Executive Program in conjunction with Massachusetts Institute of Technology – Sloan School of Management
- MBA, summa cum laude, technology and entrepreneurship, Northeastern University
- BBA, magna cum laude, management information systems and finance, Northeastern University
Ashkan Afkhami is the global leader for the Health Care practice at BCG X, Boston Consulting Group’s digital build and analytics division. He is also responsible for the firm’s Northeast system and BCG X Delivery, near and offshore capabilities.
Ashkan is passionate about making a global change through technology and new solutions. He has worked with clients in North America, Europe, and Asia to achieve their strategic goals, and has led large-scale digital transformations and builds for biopharma, medtech, and payor and provider clients. He has in-depth experience in growth strategy, go-to-market activation, acquisitions/diligences, partnerships, validated product development, commercial excellence, and data and analytics.
Before joining BCG, Ashkan was part of the founding team of GM Healthcare & Commercial Strategy at Mobiquity (acquired by Hexaware then The Carlyle Group). Ashkan has also worked at companies including Agenus, Cisco Systems, BlackRock, and Hercules Technology Growth Capital. He has served on the board of directors of several digital health and educational organizations.
